These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2522335)

  • 1. Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Br J Pharmacol; 1989 Feb; 96(2):325-32. PubMed ID: 2522335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1990 May; 36(1):97-104. PubMed ID: 2140900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychopharmacology of 5-HT3 receptors.
    Costall B; Naylor RJ; Tyers MB
    Pharmacol Ther; 1990; 47(2):181-202. PubMed ID: 2203069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of buspirone in a putative model of anxiety in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES
    J Pharm Pharmacol; 1988 Jul; 40(7):494-500. PubMed ID: 2904990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.
    Stefański R; Pałejko W; Bidziński A; Kostowski W; Płaźnik A
    Neuropharmacology; 1993 Oct; 32(10):987-93. PubMed ID: 7905195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.
    Higgins GA; Jones BJ; Oakley NR; Tyers MB
    Psychopharmacology (Berl); 1991; 104(4):545-51. PubMed ID: 1664112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
    Koulu M; Lappalainen J; Hietala J; Sjöholm B
    Psychopharmacology (Berl); 1990; 101(2):168-71. PubMed ID: 2140903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
    Costall B; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology of the 5-HT4 receptor.
    Costall B; Naylor RJ
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():11-8. PubMed ID: 8201242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.
    Hagan RM; Butler A; Hill JM; Jordan CC; Ireland SJ; Tyers MB
    Eur J Pharmacol; 1987 Jun; 138(2):303-5. PubMed ID: 2442006
    [No Abstract]   [Full Text] [Related]  

  • 13. Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam.
    Imperato A; Puglisi-Allegra S; Zocchi A; Scrocco MG; Casolini P; Angelucci L
    Eur J Pharmacol; 1990 Jan; 175(2):211-4. PubMed ID: 2311655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar effects of diazepam and the 5-HT3 receptor antagonist ICS 205-930 on place aversion conditioning.
    Papp M
    Eur J Pharmacol; 1988 Jul; 151(2):321-4. PubMed ID: 2901973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural effects in gerbils of the 5-HT3 receptor antagonists, BRL 43694 and ICS 205-930, under circumstances of high and low light intensity.
    Cutler MG
    Neuropharmacology; 1990 Jun; 29(6):515-20. PubMed ID: 2166921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal syndrome following subchronic treatment with anxiolytic agents.
    Barry JM; Costall B; Kelly ME; Naylor RJ
    Pharmacol Biochem Behav; 1987 Jun; 27(2):239-45. PubMed ID: 2888134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Oakley NR; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1989 Dec; 34(4):769-78. PubMed ID: 2576143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the amygdala is involved in the inhibitory effects of 5-HT3 receptor antagonists on alcohol drinking in rats.
    Dyr W; Kostowski W
    Alcohol; 1995; 12(4):387-91. PubMed ID: 7546338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-HT3 receptor antagonists on 5-HT and nicotinic depolarizations in guinea-pig submucosal neurones.
    Vanner S; Surprenant A
    Br J Pharmacol; 1990 Apr; 99(4):840-4. PubMed ID: 2141798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.